drugset / Trial / NCT01368562
Compassionate Use Study of Methylnaltrexone
NaSingle-groupOpen-labelTreatment
Summary
This is an open label compassionate use study of subcutaneously administered methylnaltrexone (MNTX) in participants with advance medical illness and opioid-induced constipation.
Timeline
- Start
- 2003-01-24
- Primary completion
- 2008-06-02
- Completion
- 2008-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | 0.15 mg/kg | Subcutaneous |